Steven T. Pals
0000-0002-1419-0939
Publication & Citation Trends
Publications
0 total
Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features OA
Cited by 7
Semantic Scholar
Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity OA
Cited by 54
Semantic Scholar
Skin-homing T lymphocytes: detection of cutaneous lymphocyteassociated antigen (CLA) by HECA-452 in normal human skin
Cited by 40
Semantic Scholar
Variable heavy-chain gene analysis of follicular lymphomas: subclone selection rather than clonal evolution over time. OA
Cited by 46
Semantic Scholar
Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load.
Cited by 82
Semantic Scholar
Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer. OA
Cited by 90
Semantic Scholar
Cross-talk between CD44 and c-Met in B cells.
Cited by 16
Semantic Scholar
VH gene analysis of primary cutaneous B-cell lymphomas: evidence for ongoing somatic hypermutation and isotype switching.
Cited by 48
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(75)
Proteoglycans and glycosaminoglycans research
(56)
T-cell and B-cell Immunology
(48)
Cell Adhesion Molecules Research
(47)
Chronic Lymphocytic Leukemia Research
(46)
Affiliations
University of Copenhagen
University of Parma
Merck & Co., Inc., Rahway, NJ, USA (United States)
Centers for Disease Control and Prevention
Howard Hughes Medical Institute